Antineoplastic Effect of ALK Inhibitor Crizotinib in Primary Human Anaplastic Thyroid Cancer Cells with STRN–ALK Fusion In Vitro
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25126734 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Silvia Martina Ferrari und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy. Hauptthemen laut MEDLINE: Crizotinib, Thyroid Carcinoma, Anaplastic, Anaplastic Lymphoma Kinase, Cell Proliferation. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Anaplastic thyroid cancer (ATC) is one of the deadliest human cancers and represents
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.
- Department of Surgery, Medical and Molecular Pathology and Critical Area, University of Pisa, 56126 Pisa, Italy.
- Department of Emergency Medicine, Azienda Ospedaliero-Universitaria Pisana, 56126 Pisa, Italy.
- Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy.
- Department of Pharmacy, University of Pisa, 56126 Pisa, Italy.
- Department of Surgery, "Sapienza" University of Rome, 00161 Rome, Italy.
ORCID-Profile: Armando Patrizio, Concettina La Motta, Salvatore Ulisse, Alessandro Antonelli
Zitieren
APA
Ferrari, S. M., Ragusa, F., Elia, G., Mazzi, V., Balestri, E., Botrini, C., Rugani, L., Patrizio, A., Piaggi, S., La Motta, C., Ulisse, S., Virili, C., Antonelli, A., & Fallahi, P. (2024). Antineoplastic Effect of ALK Inhibitor Crizotinib in Primary Human Anaplastic Thyroid Cancer Cells with STRN–ALK Fusion In Vitro. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25126734
Vancouver
Ferrari SM, Ragusa F, Elia G, Mazzi V, Balestri E, Botrini C, et al. Antineoplastic Effect of ALK Inhibitor Crizotinib in Primary Human Anaplastic Thyroid Cancer Cells with STRN–ALK Fusion In Vitro. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25126734
BibTeX
@article{Ferrari2024,
author = {Ferrari, Silvia Martina and Ragusa, Francesca and Elia, Giusy and Mazzi, Valeria and Balestri, Eugenia and Botrini, Chiara and Rugani, Licia and Patrizio, Armando and Piaggi, Simona and La Motta, Concettina and Ulisse, Salvatore and Virili, Camilla and Antonelli, Alessandro and Fallahi, Poupak},
title = {Antineoplastic Effect of ALK Inhibitor Crizotinib in Primary Human Anaplastic Thyroid Cancer Cells with STRN–ALK Fusion In Vitro},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25126734}
}
EUVIMED